Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-22

FDA Approved: BIMATOPROST — Original Application (Fosun Pharma USA Inc.)

View source ↗

Summary

The FDA approved the original application for bimatoprost, a generic ophthalmic solution manufactured by Fosun Pharma USA Inc., expanding access to a prostaglan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

ORIG AP for BIMATOPROST (BIMATOPROST)